Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Saranacentral Bajatama Tbk (BAJA) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Saranacentral Bajatama Tbk
Tempo Scan Pacific Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Saranacentral Bajatama Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Saranacentral Bajatama Tbk trades at Rp161 (market cap 288B, 1.21M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,500 (market cap 11.36T, 200K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 39.4× Saranacentral Bajatama Tbk's market cap, and Saranacentral Bajatama Tbk is more actively traded (1.21M versus 200K). Which is the better fit depends on your goals.

BAJATSPC
Market Cap
288B11.36T
Volume
1.21M200K
Lot
12.09K2K
Turnover
193.62M500.06M
Average Price
160.182,500.28
Value
193.62M500.06M
Indicative Equilibrium Price
1612,500
Indicative Equilibrium Volume
4100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BAJA
View details
TSPC
View details

About Saranacentral Bajatama Tbk

PT. Saranacentral Bajatama (SCB), established in 1996, is belonging to Sarana Steel Group, which was set up in 1970 and has built up its strong reputation in the worldwide steel industry. In order to provide competitive Hot-Dip Galvanized Steel Sheet/Coil to the customers, SCB take advantage of more advanced NOF (Non-Oxidation Furnace) System for production process, by which SCB differentiate itself from other competitors that use conventional processing system.

Read more on BAJA

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC